Compare Amphastar Pharmaceuticals Inc (AMPH) vs American States Water Company (AWR) Price & Performance

AMPH trades at $20.78, up 4.9% today, with a bullish technical signal supported by moving averages. The stock shows mixed earnings performance with Q2 2026 beating estimates but Q1 and Q4 2025 missing. Fundamentals remain solid with a 10.76% net margin and reasonable valuation at 12.02 P/E. Recent news highlights Q2 2026 results and strategic shift toward proprietary drugs.

Outlook is cautiously optimistic with growth supported by new product launches, though regulatory risks and earnings volatility pose challenges. Analyst sentiment is mixed with 25% buy ratings but majority hold recommendations. The stock offers value but requires monitoring of FDA developments and earnings consistency.

American States Water (AWR) trades at $87.39, up 2.01% today, with strong technical momentum showing bullish moving averages and support at $86. The company reported Q2 2026 EPS of $1.09, beating estimates by 19.1%, driven by water rate increases and 11.2% revenue growth. AWR maintains exceptional profitability with 20.52% net margins and recently announced an 8.2% dividend increase, extending its 71-year dividend growth streak.

While AWR demonstrates operational excellence and dividend reliability, the stock faces valuation concerns with a P/E of 23.65 above sector averages. Analyst sentiment is mixed with only 20% buy ratings, reflecting concerns about limited upside. Regulatory dependency and high capital expenditures present ongoing risks, though the company's monopoly position and infrastructure investments provide stability.